Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y. Huang, K.-L. Li Kidney International Volume 69, Issue 11, Pages 2049-2056 (June 2006) DOI: 10.1038/sj.ki.5001505 Copyright © 2006 International Society of Nephrology Terms and Conditions
Figure 1 Flow chart showing the enrollment and status of patients. Kidney International 2006 69, 2049-2056DOI: (10.1038/sj.ki.5001505) Copyright © 2006 International Society of Nephrology Terms and Conditions
Figure 2 Estimated mean (±2 s.e.) glomerular filtration rate according to time in the chelation group (N=15) and control group (N=15) during the study period. The patients in the chelation group received chelation therapy from month 12 to 15. #P=0.0572 and *P=0.0352 by Student's t-tests. Kidney International 2006 69, 2049-2056DOI: (10.1038/sj.ki.5001505) Copyright © 2006 International Society of Nephrology Terms and Conditions